- Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. Stone, G.W., McCullough, P.A., Tumlin, J.A., Lepor, N.E., Madyoon, H., Murray, P., Wang, A., Chu, A.A., Schaer, G.L., Stevens, M., Wilensky, R.L., O'Neill, W.W. JAMA (2003)